A136 Len/Dex ± Bortezomib for Advanced Myeloma According to Prior Neuropathy: The Impact of Cytogenetics

Meletios A Dimopoulos; Efstathios Kastritis; D. Christoulas; Magdalini Migkou; Maria Gavriatopoulou; Flora Zagouri; Μαρία Ρούσσου; Evangelos Terpos

doi:10.1016/s1557-9190(11)70475-9

Related publications

Article2011

A randomized, multicenter, phase (Ph) III study comparing carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (Dex) to LEN and Dex in patients (Pts) with relapsed multiple myeloma (MM).

Philippe Moreau, Antonio Palumbo, A. Keith Stewart, S. Vincent Rajkumar, Andrzej Jakubowiak, Kathleen G. Halka, Vesselina Goranova‐Marinova, Horia Bumbea, Kelly Pendergrass, Anca Roxana Lupu, Meletios A Dimopoulos, Albert Oriol Rocafiguera, J. G. Gandhi, Georgi Mihaylov, Tamás Masszi, J. Matous, Gustavo Fonseca, Richard Bryce, David S. Siegel

Article2021

OCEAN (OP-103): Melflufen Plus Dexamethasone (Dex) Versus Pomalidomide (Pom) and Dex in Relapsed/Refractory Multiple Myeloma (RRMM) - Impact of Prior Treatments Analysis

Meletios A Dimopoulos, Fredrik Schjesvold, María‐Victoria Mateos, Paweł Robak, Roman Hájek, Paul G. Richardson, Jakob Lindberg, Marcus Thuresson, Kajsa Larsson, Pieter Sonneveld

Article2020

POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE AFTER 1 PRIOR LINE OF THERAPY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF OPTIMMISM BY AGE, PRIOR TRANSPLANT, AND HIGH-RISK CYTOGENETICS

Meletios A Dimopoulos, Katja Weisel, Philippe Moreau, Li JR, Darrell White, J.S. Miguel, Pieter Sonneveld, Monika Engelhardt, Matthew Jenner, Alessandro Corso, J. Dürig, Michel Pavic, Morten Salomo, Eva Casal, Ruixuan Jiang, Thao Thi Thu Nguyen, Teresa Peluso, Paul G. Richardson

Article2019

Pomalidomide + Bortezomib + Dexamethasone After One Prior Line of Therapy in Bortezomib-Pretreated Multiple Myeloma: Subanalysis of OPTIMISMM

Meletios A Dimopoulos, Katja Weisel, Philippe Moreau, Larry D. Anderson, Darrell White, Jesús F. San Miguel, Pieter Sonneveld, Monika Engelhardt, Matthew Jenner, Alessandro Corso, Jan Dürig, Michel Pavic, Morten Salomo, Eva Casalz, Ruiyun Jiang, Shankar Srinivasan, Tuong Vi Nguyen, Amine Bensmaine, Teresa Peluso, Paul G. Richardson

Letter2021

Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma

María‐Victoria Mateos, Maria Gavriatopoulou, Thierry Façon, Holger W. Auner, Xavier Leleu, Roman Hájek, Meletios A Dimopoulos, Sosana Delimpasi, Maryana Simonova, Ivan Špıčka, Luděk Pour, Iryna Kriachok, Halyna Pylypenko, Vadim Doronin, Ganna Usenko, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P. Venner, Mamta Garg, Don A. Stevens, Hang Quach, Sundar Jagannath,